Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.
about
Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomesPeripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy.The safety of available treatments for chronic constipation.Targeting Small Bowel Receptors to Treat Constipation and Diarrhea.Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications.Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study.Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers.Randomized phase 3 and extension studies: Efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer.
P2860
Q36696556-4D1FA822-D9F5-4CAD-B89F-A2E816B2FA0AQ37603682-DFEEE3AC-0350-4290-8DCA-5D445BF31EFAQ38653195-3BB56CE9-CD3A-47D5-A4F0-80D55262521AQ38673439-6FB564B5-7AB5-477F-8287-475EABFCC908Q38911748-FF7DA02A-B26D-45DD-8C88-84AD96F5EF66Q39151326-59D02CE4-CC37-4696-B914-4C9B32E41839Q43075638-C2167809-AFF8-4954-8300-5C01D07641A6Q44341425-DA5FD68E-5D56-42C8-AC7D-0BA6A4B2646EQ49926308-C2DEB39F-2EA6-439E-9E42-B85CEECEC476Q53095490-7BBB179B-DCDC-440B-8070-5FE29F81F1A6Q55231627-B2447C29-A38F-46BF-BAFF-15F43F04E5E3
P2860
Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Efficacy and Safety of Methyln ...... A Placebo Crossover Analysis.
@ast
Efficacy and Safety of Methyln ...... A Placebo Crossover Analysis.
@en
type
label
Efficacy and Safety of Methyln ...... A Placebo Crossover Analysis.
@ast
Efficacy and Safety of Methyln ...... A Placebo Crossover Analysis.
@en
prefLabel
Efficacy and Safety of Methyln ...... A Placebo Crossover Analysis.
@ast
Efficacy and Safety of Methyln ...... A Placebo Crossover Analysis.
@en
P2093
P2860
P921
P1476
Efficacy and Safety of Methyln ...... A Placebo Crossover Analysis.
@en
P2093
Andrew C Barrett
Craig Paterson
Eugene R Viscusi
William P Forbes
P2860
P356
10.1097/AAP.0000000000000341
P577
2015-12-08T00:00:00Z